Efficacy and safety of the ghrelin-O-acyltransferase inhibitor BI 1356225 in overweight/obesity: Data from two Phase I, randomised, placebo-controlled studies

Metabolism. 2023; 143.

Bianzano S, Henrich A, Herich L, Kalsch B, Sarubbi D, Seitz F, Forst T